Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer

Author:

Disis Mary L.12,Taylor Matthew H.3,Kelly Karen4,Beck J. Thaddeus5,Gordon Michael6,Moore Kathleen M.7,Patel Manish R.8,Chaves Jorge9,Park Haeseong10,Mita Alain C.11,Hamilton Erika P.12,Annunziata Christina M.13,Grote Hans Juergen14,von Heydebreck Anja15,Grewal Jaspreet1617,Chand Vikram1618,Gulley James L.19

Affiliation:

1. Department of Medicine, UW Medicine Cancer Vaccine Institute, University of Washington School of Medicine, Seattle

2. Editor, JAMA Oncology

3. Knight Cancer Institute, Oregon Health and Science University, Portland

4. Davis Comprehensive Cancer Center, University of California, Sacramento

5. Medical Oncology, Highlands Oncology Group, Fayetteville, Arkansas

6. HonorHealth Research Institute, HonorHealth Virginia G. Piper Cancer Care Network, Scottsdale, Arizona

7. Peggy and Charles Stephenson Oklahoma Cancer Center/Sarah Cannon Research Institute, University of Oklahoma, Oklahoma City

8. Medical Oncology, Sarah Cannon Research Institute, Florida Cancer Specialists, Sarasota

9. Medical Oncology, Northwest Medical Specialties, Tacoma, Washington

10. Division of Oncology, Washington University School of Medicine, St Louis, Missouri

11. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California

12. Medical Oncology, Tennessee Oncology, Sarah Cannon Research Institute, Nashville

13. Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

14. Clinical Biomarkers and Companion Diagnostics, Merck KGaA, Darmstadt Germany

15. Global Biostatistics, Merck KGaA, Darmstadt, Germany

16. Global Clinical Development, EMD Serono, Billerica, Massachusetts

17. currently at Hematology, Norton Healthcare, Louisville, Kentucky

18. currently at Global Development, AstraZeneca Pharmaceuticals LP, Gaithersburg, Maryland

19. Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 335 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3